HIMS expands its AI-powered, subscription-based care model globally, backed by $870 million in fresh funding for growth.
Vous n'êtes pas connecté
Maroc - ZACKS.COM - All Stories - 31/Oct 18:58
HIMS scales AI-driven care with new hormonal health lines, global expansion plans and a $870 million funding boost.
HIMS expands its AI-powered, subscription-based care model globally, backed by $870 million in fresh funding for growth.
HIMS expands its AI-powered, subscription-based care model globally, backed by $870 million in fresh funding for growth.
) Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results Revenue of nearly $600 million, up 49% year-over-year in Q3 2025 Net...
Hims & Hers benefits from strong platform engagement and hormonal health launches ahead of third-quarter 2025 earnings.
Hims & Hers benefits from strong platform engagement and hormonal health launches ahead of third-quarter 2025 earnings.
Hims & Hers Health (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get...
Hims & Hers Health (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get...
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 0.00% and +2.62%, respectively, for the quarter ended September 2025. Do the...
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 0.00% and +2.62%, respectively, for the quarter ended September 2025. Do the...
Hims & Hers Health, Inc. (HIMS) reached $47.12 at the closing of the latest trading day, reflecting a -2.3% change compared to its last close.